Showing results (21-30 of 69) with videos related to

Sort By:
Pageof 7
The International Journal of Neuropsychopharmacology|July 30, 2015
Cholinesterase Inhibitors for Lewy Body Disorders: A Meta-AnalysisShinji Matsunaga, Taro Kishi, Ichiro Yasue, et al.
Geriatrics & Gerontology International|September 4, 2019
Increase in direct social care costs of Alzheimer's disease in Japan depending on dementia severityHajime Takechi, Atsuko Kokuryu, Akira Kuzuya, et al.
Journal of Alzheimer'S Disease : JAD|September 25, 2015
Histamine H3 Receptor Antagonists for Alzheimer's Disease: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled TrialsMomoko Kubo, Taro Kishi, Shinji Matsunaga, et al.
Neuropsychiatric Disease and Treatment|December 20, 2014
Iminodibenzyl class antipsychotics for schizophrenia: a systematic review and meta-analysis of carpipramine, clocapramine, and mosapramineTaro Kishi, Shinji Matsunaga, Yuki Matsuda, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 6, 2015
Antipsychotic medications for the treatment of delirium: a systematic review and meta-analysis of randomised controlled trialsTaro Kishi, Tomoya Hirota, Shinji Matsunaga, et al.
Anticancer Research|May 1, 2007
Incadronate induces cell detachment and apoptosis in prostatic PC-3 cellsShinji Matsunaga, Kazuhiro Iguchi, Shigeyuki Usui, et al.
Anticancer Research|August 5, 2006
Inhibition of caveolin-1 expression by incadronate in PC-3 prostate cellsKazuhiro Iguchi, Shinji Matsunaga, Toru Nakano, et al.
Neuropsychiatric Disease and Treatment|December 24, 2016
Efficacy and tolerability of topiramate-augmentation therapy for schizophrenia: a systematic review and meta-analysis of randomized controlled trialsYuji Okuyama, Kazuto Oya, Shinji Matsunaga, et al.
Journal of Alzheimer'S Disease : JAD|January 13, 2016
Serotonin 2A Receptor Inverse Agonist as a Treatment for Parkinson's Disease Psychosis: A Systematic Review and Meta-analysis of Serotonin 2A Receptor Negative ModulatorsIchiro Yasue, Shinji Matsunaga, Taro Kishi, et al.
European Archives of Psychiatry and Clinical Neuroscience|August 26, 2015
Efficacy and safety of oxytocin augmentation therapy for schizophrenia: an updated systematic review and meta-analysis of randomized, placebo-controlled trialsKazuto Oya, Yuki Matsuda, Shinji Matsunaga, et al.
Pageof 7